IVF vs ICSI and IMSI: Which Fertilisation Method Is Right for You?

5 min read

Compare IVF vs ICSI, understand how IMSI works, and learn which fertility factors may influence the fertilisation method recommended in Nepal.

The main difference in IVF vs ICSI is how sperm fertilises the egg. In conventional IVF, prepared sperm and retrieved eggs are placed together in the laboratory so that fertilisation can occur. In ICSI, an embryologist selects one sperm and injects it directly into an egg.

IMSI is not a separate replacement for IVF. It is an additional sperm-selection method that may be used before ICSI. It allows sperm to be viewed at very high magnification, but current evidence does not show that IMSI improves the chance of having a baby for most fertility patients.

The appropriate method depends on semen results, previous fertilisation, egg factors, treatment history and the reason IVF is being performed.

How are IVF, ICSI and IMSI related?

IVF is the overall assisted-reproduction treatment, while conventional IVF and ICSI are different laboratory methods for fertilising the eggs collected during that treatment.

IMSI goes one step further in sperm selection, but the selected sperm must still be injected into an egg through ICSI.

A typical IVF cycle may involve:

  1. Ovarian stimulation
  2. Monitoring
  3. Egg retrieval
  4. Semen collection or sperm retrieval
  5. Fertilisation using conventional IVF or ICSI
  6. Embryo culture
  7. Embryo transfer or freezing
  8. Pregnancy testing

New Life IVF includes IVF, ICSI and IMSI within its range of assisted-reproduction services in Kathmandu.

IVF vs ICSI vs IMSI: What is the difference?

FeatureConventional IVFICSIIMSI
What it isA fertilisation method within IVFA fertilisation method within IVFA sperm-selection add-on used with ICSI
How sperm meets the eggMultiple prepared sperm are placed around each eggOne sperm is injected into one mature eggSperm are examined at high magnification before one is injected through ICSI
Main laboratory equipmentCulture dish and incubatorMicromanipulation and injection equipmentHigh-magnification imaging plus ICSI equipment
Common clinical considerationSuitable sperm parameters and no strong reason for microinjectionSignificant male factor, surgically retrieved sperm or previous fertilisation failureSelected situations where specialised sperm assessment is considered
Does it guarantee fertilisation?NoNoNo
Does it guarantee embryo development?NoNoNo
Does it guarantee pregnancy?NoNoNo
Routine use for everyoneNot applicableNot recommended without an indicationEvidence of benefit is uncertain for most patients

The most important practical distinction is that ICSI bypasses several steps involved in sperm reaching and penetrating the egg, while IMSI only changes how a sperm is visually selected before ICSI.

What is conventional IVF fertilisation?

In conventional IVF, an embryologist places a prepared concentration of sperm with the retrieved eggs in a laboratory dish. The sperm must then reach and penetrate an egg without being individually injected.

The embryology team later checks whether fertilisation has occurred and monitors any resulting embryos.

Conventional IVF does not mean that conception happens naturally inside the body. Egg retrieval, semen preparation, fertilisation and embryo culture still take place as part of an assisted-reproduction cycle.

Patients who need a broader explanation of stimulation, egg retrieval and embryo transfer can review the clinic’s IVF treatment process.

When may conventional IVF be considered?

A fertility team may consider conventional insemination when:

  • semen parameters are considered suitable;
  • there is no severe male-factor diagnosis;
  • sperm have not been surgically retrieved;
  • there is no history of total or unexpectedly poor fertilisation;
  • and no other specific reason supports ICSI.

The final decision should consider the complete clinical picture rather than one semen value.

Potential advantages of conventional IVF

  • It allows sperm to interact with the egg without direct microinjection.
  • It avoids an additional invasive laboratory procedure on each mature egg.
  • It may require less laboratory manipulation.
  • It may cost less than adding ICSI.
  • Evidence does not support replacing it routinely with ICSI when there is no relevant indication.

ASRM’s 2026 committee opinion concludes that routine ICSI is not recommended in the absence of male-factor infertility or previous fertilisation problems. It reports that routine ICSI has not improved live-birth rates for patients without a clear indication.

Limitations of conventional IVF

  • Complete fertilisation failure can occur.
  • It may be unsuitable when very few usable sperm are available.
  • It may not be preferred with surgically retrieved sperm.
  • The team cannot directly place a selected sperm inside each mature egg.
  • A previous pattern of poor fertilisation may influence the next plan.

Fertilisation failure can also occur after ICSI, so neither method provides certainty.

What is ICSI?

ICSI stands for intracytoplasmic sperm injection. It is a laboratory technique in which an embryologist selects one sperm and injects it directly into the cytoplasm of a mature egg.

ICSI is performed as part of an IVF cycle. The patient still undergoes ovarian stimulation, egg retrieval, embryo culture and, where appropriate, embryo transfer.

When is ICSI commonly considered?

ICSI may be considered when a fertility evaluation identifies:

  • very low sperm concentration;
  • severely reduced sperm movement;
  • very limited numbers of usable sperm;
  • sperm obtained through a surgical retrieval procedure;
  • previous failed or unexpectedly poor fertilisation with conventional insemination;
  • fertilisation of previously frozen eggs;
  • or selected forms of preimplantation genetic testing.

ASRM states that ICSI may be appropriate for prior poor or absent fertilisation with conventional insemination, previously cryopreserved eggs and selected PGT-M cycles. It does not recommend routine ICSI for all patients without male-factor infertility.

Does ICSI overcome male infertility?

ICSI can help overcome certain barriers to fertilisation, particularly when sperm numbers, movement or availability are severely limited. It does not correct the underlying cause of male infertility, guarantee a genetically healthy embryo or remove the need for male evaluation.

A proper assessment may include:

  • medical and reproductive history;
  • semen analysis;
  • physical examination where indicated;
  • hormone testing;
  • genetic investigation in selected cases;
  • and referral to an appropriate male-reproductive specialist.

Male-factor infertility should not automatically be reduced to “use ICSI.” Some causes may have broader health or reproductive implications that require evaluation.

Does ICSI guarantee fertilisation?

No. A sperm can be placed inside a mature egg, but normal fertilisation and embryo development still depend on biological factors involving both the sperm and egg.

Possible reasons fertilisation may not proceed normally include:

  • egg immaturity;
  • egg activation problems;
  • sperm-related factors;
  • egg-related factors;
  • laboratory or procedural challenges;
  • and biological factors that cannot always be predicted beforehand.

Does ICSI improve live-birth rates for everyone?

No. ICSI may reduce the risk of failed fertilisation in selected circumstances, but increasing fertilisation does not automatically increase live birth.

ASRM’s current review states that routine ICSI does not improve live-birth outcomes in cases without male-factor infertility or previous fertilisation failure. The review also finds no demonstrated live-birth benefit from routine ICSI solely for unexplained infertility, advanced maternal age, diminished ovarian reserve or low egg yield.

This is why “ICSI is more advanced” is not a sufficient clinical reason to use it for every retrieved egg.

Mid-article CTA: The decision between conventional IVF and ICSI should follow an evaluation of both partners—not a preference for the most complex procedure. New Life IVF offers comprehensive fertility screening to help identify the factors relevant to an individual treatment plan.

What is IMSI?

IMSI stands for intracytoplasmic morphologically selected sperm injection. It is a sperm-selection technique used before ICSI.

During IMSI, sperm are viewed through a system that provides much higher magnification than is normally used during standard ICSI. An embryologist examines visible features of the sperm and selects one for injection into an egg.

The HFEA describes IMSI as a sperm-selection method used in ICSI and notes that the technique may use magnification above 6,000 times.

Is IMSI a separate fertility treatment?

No. IMSI cannot replace ovarian stimulation, egg retrieval, fertilisation, embryo culture or embryo transfer.

The sequence is:

IVF cycle → high-magnification sperm selection through IMSI → sperm injection through ICSI

For this reason, treatment descriptions should avoid presenting IMSI as a third independent pathway beside IVF and ICSI.

Is IMSI better than standard ICSI?

Current evidence does not establish that IMSI increases the chance of having a baby for most patients.

The HFEA gives IMSI a grey rating for increasing the chance of having a baby, meaning there is insufficient moderate- or high-quality evidence to determine whether it is effective for that outcome.

NICE’s 2026 evidence review similarly concludes that the effects of IMSI compared with standard ICSI are uncertain. Because IMSI adds expense without a clearly established clinical benefit, the committee considered standard ICSI more cost-effective.

When might IMSI be discussed?

Some clinics may discuss IMSI in selected situations involving:

  • marked sperm-morphology concerns;
  • repeated unsuccessful treatment;
  • previous poor embryo development;
  • or a specialist laboratory assessment.

However, an association between a clinical situation and the use of IMSI does not prove that IMSI will improve live-birth outcomes. Patients should ask for the specific evidence supporting its use in their case.

Questions to ask before paying for IMSI

  1. What finding in our results supports IMSI?
  2. Is this recommendation based on semen morphology alone?
  3. What outcome is expected to improve?
  4. Is the evidence about fertilisation, pregnancy or live birth?
  5. Is IMSI part of a study or an established clinic protocol?
  6. What additional cost is involved?
  7. What would you recommend if we decline IMSI?
  8. How many similar patients at this clinic have received it?
  9. Is the clinic able to provide audited outcome data?
  10. Are there other investigations that should come first?

An ethical consent discussion should distinguish a biologically plausible technique from a treatment proven to improve the outcome that matters to patients.

How does a fertility specialist choose between IVF and ICSI?

A specialist should base the recommendation on the couple’s diagnosis, sperm availability, previous treatment response, egg-related factors and laboratory plan.

The decision usually involves three levels.

Level 1: Is IVF appropriate?

The team first determines whether an IVF cycle is suitable at all.

Relevant factors may include:

  • blocked or damaged fallopian tubes;
  • significant male infertility;
  • endometriosis;
  • unsuccessful lower-intensity treatment;
  • reduced reproductive time related to age;
  • genetic indications;
  • fertility preservation needs;
  • or other diagnosed fertility problems.

Some patients may instead be advised to consider timed intercourse, ovulation treatment, IUI, surgery, donor treatment or another pathway.

Level 2: How should the eggs be fertilised?

Once IVF is planned, the team decides whether to use conventional insemination, ICSI or, in selected circumstances, a split approach.

The decision may consider:

  • sperm concentration;
  • progressive motility;
  • total usable sperm;
  • sperm source;
  • previous fertilisation history;
  • number and maturity of retrieved eggs;
  • use of frozen eggs;
  • and the purpose of any planned embryo testing.

Level 3: Is an additional sperm-selection technique justified?

Only after ICSI is selected should an add-on such as IMSI be considered.

The team should explain:

  • the clinical reason;
  • the quality of supporting evidence;
  • the expected outcome;
  • limitations;
  • added laboratory time;
  • and added cost.

“Advanced technology” alone does not establish medical necessity.

Practical decision framework

Clinical situationMethod that may be discussedImportant limitation
Suitable semen parameters and no previous fertilisation problemConventional IVFFailed fertilisation remains possible
Severe reduction in sperm number or movementICSIDoes not guarantee embryo development
Surgically retrieved spermICSIMale evaluation may still be necessary
Previous total or unexpectedly low fertilisationICSI in a later cycleThe cause may involve sperm, egg or both
Frozen eggs being fertilisedICSI commonly usedPregnancy still depends on egg and embryo factors
PGT-M cycleICSI may be considered to reduce contamination riskNot every type of PGT requires ICSI
Advanced age without male factorConventional IVF may remain suitableICSI has not been shown to reverse age-related egg factors
Low ovarian reserve aloneMethod chosen from full contextRoutine ICSI has not shown a live-birth advantage
Morphology concern with otherwise adequate semenIndividual assessmentMorphology alone may not prove ICSI or IMSI benefit
Consideration of IMSISpecialist discussion after ICSI decisionLive-birth benefit remains uncertain

This table describes issues for clinical discussion, not an individual treatment prescription.

What tests may influence the decision?

Semen analysis

A semen analysis may assess:

  • sperm concentration;
  • movement;
  • morphology;
  • semen volume;
  • and other laboratory characteristics.

One result may not fully represent sperm production because semen parameters can vary. A repeat test or additional assessment may be advised.

Fertility assessment for the female partner

The evaluation may include:

  • age and reproductive history;
  • menstrual and ovulation history;
  • ovarian-reserve assessment;
  • pelvic ultrasound;
  • tubal evaluation where relevant;
  • previous pregnancy or miscarriage;
  • and previous treatment response.

Previous embryology records

For patients with an earlier IVF cycle, the team should review:

  • number of eggs retrieved;
  • number of mature eggs;
  • fertilisation method;
  • normal fertilisation rate;
  • embryo-development pattern;
  • number of usable embryos;
  • transfer information;
  • and pregnancy outcome.

A previous unsuccessful cycle should not automatically lead to every available add-on. The proposed change should address a documented problem.

What are the benefits and limitations of ICSI?

Potential benefits

ICSI may:

  • permit fertilisation when very few sperm are available;
  • enable use of surgically retrieved sperm;
  • reduce the risk of failed fertilisation in selected patients with a relevant history;
  • allow fertilisation of cryopreserved eggs;
  • and support selected genetic-testing procedures.

Limitations

ICSI:

  • does not improve egg quality;
  • does not guarantee normal fertilisation;
  • does not guarantee blastocyst development;
  • does not prevent miscarriage;
  • does not guarantee live birth;
  • may add laboratory cost and complexity;
  • and does not improve outcomes routinely for every non-male-factor case.

ASRM notes that ICSI involves additional laboratory expertise, resources, effort and cost. It recommends weighing those factors against the expected clinical benefit.

Possible procedural considerations

ICSI requires removal of surrounding cells from the egg so that maturity can be assessed. The egg is then held and injected using micromanipulation equipment.

A small proportion of eggs may not survive manipulation, and some injected eggs may not fertilise normally. The clinic should explain its own laboratory consent information without presenting rare or uncertain events as inevitable.

Common misconceptions about IVF, ICSI and IMSI

“ICSI is a stronger form of IVF.”

ICSI is not simply “stronger.” It is a different way of fertilising eggs within an IVF cycle.

“The newest technique must have the highest success rate.”

Technological complexity does not prove better live-birth outcomes. A technique should be used when its benefits are supported for the patient’s clinical situation.

“ICSI solves every male infertility problem.”

ICSI can assist fertilisation, but male infertility may require diagnostic, genetic, hormonal, medical or surgical evaluation.

“IMSI guarantees selection of genetically normal sperm.”

IMSI evaluates visible sperm morphology at high magnification. It does not directly confirm that the selected sperm is genetically normal.

“Poor sperm morphology always means IMSI is required.”

Not necessarily. Morphology is one part of semen assessment, and the benefit of IMSI remains uncertain for most patients.

“An ICSI fertilisation rate is the same as an IVF success rate.”

No. Fertilisation is an early laboratory outcome. It does not confirm implantation, pregnancy or live birth.

“If ICSI is offered, conventional IVF must be unsafe.”

No. Conventional IVF remains an established fertilisation method and may be appropriate when there is no indication for microinjection.

How should you compare an IVF clinic in Nepal?

A reliable IVF clinic should explain not only what technology it offers but also why a method is being recommended.

Ask the clinic:

About the diagnosis

  • What is the identified cause of infertility?
  • Have both partners been assessed?
  • Are any tests being repeated?
  • Could the findings affect general health as well as fertility?

About conventional IVF and ICSI

  • Why are you recommending this fertilisation method?
  • What is the main alternative?
  • What happened in comparable previous cycles?
  • Would all mature eggs receive the same method?
  • What happens if no eggs fertilise?
  • How will fertilisation be reported?

About IMSI and add-ons

  • Is the technique optional?
  • What evidence supports it in our situation?
  • Does the evidence show a live-birth benefit?
  • What additional fee applies?
  • Is the recommendation based on clinic data or published guidance?
  • What are the consequences of declining it?

About the laboratory

  • Who performs ICSI?
  • How are sperm selected?
  • How are eggs, sperm and embryos identified?
  • How is laboratory performance monitored?
  • How are unexpected fertilisation results reviewed?
  • Can the clinic explain its fertilisation data by patient category?

About outcomes

  • Are results reported as pregnancy or live birth?
  • Are they calculated per cycle started or transfer?
  • Are age groups separated?
  • Are conventional IVF and ICSI results reported separately?
  • Are own-egg and donor-egg cycles separated?
  • How many cycles are included?

New Life IVF identifies fertility specialists and a multidisciplinary fertility team through its doctor directory. Its stated care model focuses on personalised, evidence-based fertility care.

Which method is right for you?

There is no universally superior option.

Conventional IVF may be appropriate when there is no severe male-factor problem or previous fertilisation concern. ICSI may be appropriate when sperm number, movement, source or previous fertilisation history makes direct injection clinically useful.

IMSI may be discussed as an additional sperm-selection step in selected cases, but patients should be told that its effect on live birth remains uncertain.

The safest conclusion is not “choose the most advanced method.” It is:

Choose the method that addresses the diagnosed fertilisation problem with the least unnecessary intervention, cost and uncertainty.

Key takeaways

  • IVF is the overall treatment cycle.
  • Conventional IVF and ICSI are methods of fertilising eggs during IVF.
  • IMSI is a sperm-selection add-on used with ICSI.
  • ICSI is particularly relevant in selected male-factor and previous-fertilisation cases.
  • Routine ICSI does not improve live-birth outcomes for every patient.
  • Advanced maternal age or low ovarian reserve alone does not automatically make ICSI better.
  • IMSI has not been shown to improve the chance of having a baby for most patients.
  • A recommendation should follow evaluation of both partners.
  • Patients should ask about evidence, outcomes, alternatives and added costs.

Frequently Asked Questions

What is the main difference between IVF and ICSI?

The difference is how fertilisation occurs. In conventional IVF, multiple prepared sperm are placed with each egg. In ICSI, an embryologist injects one selected sperm into a mature egg. Both methods take place within an IVF treatment cycle.

Is ICSI part of IVF?

Yes. ICSI is a laboratory fertilisation method used during IVF. It does not replace ovarian stimulation, egg retrieval, embryo culture or embryo transfer. Calling IVF and ICSI entirely separate treatments can therefore be misleading.

What is IMSI?

IMSI is a high-magnification sperm-selection method used before ICSI. An embryologist examines sperm in greater visual detail, selects one and then injects it into an egg using ICSI. IMSI is an add-on rather than a complete fertility-treatment cycle.

Is IMSI better than ICSI?

It has not been established as better for most patients. The HFEA reports insufficient moderate- or high-quality evidence to determine whether IMSI increases the chance of having a baby. Its potential benefit, limitations and additional cost should be discussed before treatment.

When is ICSI usually recommended?

ICSI may be considered for severe male-factor infertility, very limited usable sperm, surgically retrieved sperm, previous failed or poor fertilisation, frozen eggs and selected PGT-M cycles. The recommendation should be based on diagnosis and treatment history.

Does ICSI improve pregnancy rates for everyone?

No. Routine ICSI has not been shown to improve live-birth rates for patients without male-factor infertility or previous fertilisation problems. It may reduce fertilisation failure in selected situations, but that does not automatically increase the live-birth rate.

Can conventional IVF be used for male infertility?

It may be used in mild or selected male-factor situations when enough suitable sperm are available, but the decision depends on the complete semen assessment and treatment history. More severe sperm problems may support the use of ICSI.

What happens if fertilisation failed in a previous IVF cycle?

The clinical and laboratory teams should review egg maturity, semen parameters, fertilisation conditions and previous embryology records. ICSI may be discussed in a future cycle, but the team should also consider whether sperm, egg or other factors contributed.

Does poor sperm morphology automatically mean ICSI is necessary?

No. Sperm morphology should be interpreted with concentration, movement, total usable sperm and clinical history. Current evidence does not support assuming that an isolated morphology result always makes ICSI superior to conventional IVF.

Does ICSI select the healthiest sperm?

The embryologist selects a sperm based on movement and visible features under the laboratory microscope. This does not prove that the sperm is genetically normal or guarantee healthy embryo development.

Can ICSI prevent miscarriage?

No. Miscarriage can relate to embryo chromosomes, age, uterine factors, health conditions and other causes. ICSI assists fertilisation but does not prevent every cause of pregnancy loss.

Does ICSI improve egg quality?

No. ICSI changes how sperm enters the egg. It does not reverse age-related egg changes, increase ovarian reserve or guarantee that an egg will develop into a viable embryo.

Is ICSI more expensive than conventional IVF?

It generally adds laboratory work, specialised equipment and professional time, so it may involve an additional charge. Patients should request a written cost breakdown and ask whether the proposed indication is supported by evidence.

Is IMSI more expensive than ICSI?

It may add cost because it requires an additional high-magnification sperm-selection step. NICE’s evidence review concluded that the clinical benefit remains uncertain and that standard ICSI was more cost-effective in the evidence it assessed.

Which option has the highest success rate?

No method has the highest rate for every patient. Outcomes depend on age, egg and sperm health, diagnosis, embryo development, laboratory performance and uterine factors. The most appropriate fertilisation method is the one supported by the individual clinical findings.

Can a clinic guarantee success with ICSI or IMSI?

No. A clinic should not guarantee fertilisation, pregnancy or live birth. Even when sperm is injected into an egg, fertilisation and embryo development may not occur normally.

How does a doctor decide between IVF and ICSI?

The decision is based on semen results, sperm source, previous fertilisation, number of mature eggs, planned genetic testing and the couple’s wider diagnosis. Both partners should be evaluated before the method is finalised.

Should every retrieved egg receive ICSI?

Not automatically. Routine ICSI for all eggs is not recommended when there is no male-factor indication or previous fertilisation problem. The clinic should explain why ICSI is being suggested and what evidence supports it.

When should a couple consult an IVF specialist?

A couple should seek fertility evaluation when pregnancy has not occurred within the clinically appropriate period or sooner when there is a known fertility concern. Irregular ovulation, tubal disease, endometriosis, significant semen abnormalities or previous treatment failure may justify earlier assessment.

Back to Articles